Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRecord history now includes the last known status with sponsor, date, and verification details.SummaryDifference0.7%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check23 days agoChange DetectedA new revision entry v3.4.3 was added. The previous entry v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.2 was added and earlier notices about funding and operating status were removed. These are administrative site updates that do not affect trial data or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operations. Updated the site version to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.8%

- Check66 days agoChange DetectedThe history view received minor UI updates, including a Show glossary option, color-coded highlight explanations, and an updated revision tag (v3.4.0 replacing v3.3.4). These changes do not affect core trial data or content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.